We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Offer for Subscription

22 Sep 2017 18:25

RNS Number : 6312R
Maven Income & Growth VCT 4 PLC
22 September 2017
 

Joint Announcement

 

Offer for Subscription

 

22 September 2017

The board of directors of Maven Income and Growth VCT 3 PLC ("Maven VCT 3") and Maven Income and Growth VCT 4 PLC ("Maven VCT 4") (together the "Companies" and each a "Company") are pleased to announce that they have published a joint Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription for new Ordinary Shares of 10p each in the Companies to raise, in aggregate, up to £30 million with over-allotment facilities of up to, in aggregate, a further £10 million (before issue costs) (the "Offers").

 

The Companies have also published a joint circular (the "Circular") seeking the approval of their respective shareholders for matters in connection with the Offers, each Company giving notice of a general meeting to be held on 8 November 2017 (the "General Meeting").

 

The Offers will open on 22 September 2017 and are expected to close no later than 3 April 2018 in relation to the tax year 2017/18 and on 20 April 2017 in relation to the tax year 2018/19 (unless the relevant Offer is fully subscribed by an earlier date or previously extended by the relevant board to no later than 14 September 2018).

 

Each Offer is conditional on the passing of all the resolutions at the relevant General Meeting.

Pursuant to individual offer agreements dated 22 September 2017 relating to each Offer between, among others, each relevant Company and Maven Capital Partners LLP ("Maven"), Maven, as the administrator of the Offer, will receive an offer administration fee of 2.5% of the application amount in relation to each accepted application, with reductions to the fee applying in certain cases (for instance, early applications under the Offers). Maven as the investment manager of each Company is a related party of each Company under the Listing Rules, and the payment of such a fee by the Company to Maven is a transaction to which Listing Rule 11.1.10R applies.

Further, William Nixon has expressed his intention, prior to the close of each of the Offers, to subscribe £50,000 in Maven VCT 3 and £50,000 in Maven VCT 4 under the relevant Offer. As a director of each of the Companies, William Nixon is a related party of the relevant Company under the Listing Rules and consequently each subscription is a transaction to which Listing Rule 11.1.10R applies.

Maven VCT 3 has also agreed with Maven that with effect from 1 December 2017 Maven will also be entitled to a performance incentive fee, for each six month period ending 31 May and 30 November, of an amount equal to 15% of any increase in the total return (before applying any performance incentive fee) as at the end of the relevant six month period to the total return (after accruing for the performance incentive fee payable for that period) compared to the end of the last six month period on which a performance incentive fee was paid. Payments in relation to any performance incentive fee shall not exceed £890,000 in relation to any rolling twelve month period ending on the date of the proposed payment. Maven and Maven VCT 3 have also agreed to vary the terms of a co-investment agreement (which enables employees and officers of Maven to co-invest with Maven VCT 3 in certain new and follow-on investments) with the effect that the 8% total investment limit (which applies to the investments that can be made by such employees and officers) will be reduced to 5% with effect from 1 December 2017. As Maven is a related party of Maven VCT 3 under the Listing Rules, the introduction of a performance incentive fee payable by that Company to Maven, together with the variation of the co-investment arrangements, are transactions to which Listing Rule 11.1.10R applies.

To obtain a copy of the Securities Note, private investors and financial advisers should call Maven Capital Partners LLP on 0141 306 7400. A downloadable version of the Securities Note will also be available from the each of the Company's websites: http://www.mavencp.com/migvct3 and http://www.mavencp.com/migvct4 .

 

Copies of the Prospectus and Circular are available, free of charge, from Maven Capital Partners UK LLP at Kintyre House, 205 West George Street, Glasgow G2 2LW.

 

In accordance with the Listing Rules, the Prospectus and Circular have been submitted to the National Storage Mechanism and will shortly be available for inspection at:

 

www.morningstar.co.uk/uk/NSM.

 

Any enquiries in respect of the Offers should be directed to:

Maven Capital Partners UK LLP

Telephone: 0141 306 7400E-mail: enquiries@mavencp.com

Maven Capital Partners UK LLPSecretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRPGUWPBUPMGMP
Date   Source Headline
4th Mar 20155:16 pmRNSAnnual Financial Report
26th Feb 201512:09 pmRNSIssue of Equity
26th Feb 201511:24 amRNSDirector/PDMR Shareholding
20th Feb 20152:47 pmRNSIssue of Equity
11th Feb 201511:40 amRNSNet Asset Value(s)
5th Feb 20155:00 pmRNSStatement re Offers for Subscription
3rd Feb 20153:07 pmRNSStatement re Offers for Subscription
30th Jan 20154:53 pmRNSStatement re Offers for Subscription
20th Jan 20159:48 amRNSStatement re Offers for Subscription
9th Jan 201510:17 amRNSDirector Declaration
7th Jan 20152:11 pmRNSStatement re Offers for Subscription
6th Nov 20145:23 pmRNSTransaction in Own Shares
5th Nov 20142:30 pmRNSTransaction in Own Shares
4th Nov 20144:46 pmRNSTransaction in Own Shares
4th Nov 20144:41 pmRNSDirector/PDMR Shareholding
20th Oct 20146:27 pmRNSStatement re Prospectus and Circular
10th Oct 20142:46 pmRNSInterim Management Statement
3rd Oct 20144:23 pmRNSTotal Voting Rights
1st Oct 201410:50 amRNSStatement re Joint Offer for Subscription
26th Aug 20145:07 pmRNSTransaction in Own Shares
13th Aug 20144:41 pmRNSTransaction in Own Shares
12th Aug 20143:36 pmRNSTransaction in Own Shares
11th Aug 20144:22 pmRNSTransaction in Own Shares
4th Aug 20145:26 pmRNSDirector/PDMR Shareholding
31st Jul 20143:06 pmRNSDirector/PDMR Shareholding
31st Jul 20143:03 pmRNSTransaction in Own Shares
29th Jul 20143:44 pmRNSDirector/PDMR Shareholding
29th Jul 201412:37 pmRNSHalf Yearly Report
4th Jul 20144:31 pmRNSReplacement re Issue of Equity
2nd Jul 20149:50 amRNSIssue of Equity
28th May 20145:09 pmRNSOffer for Subscription Update
30th Apr 20142:25 pmRNSDirectorate Change
30th Apr 20142:18 pmRNSAGM Results
30th Apr 20147:01 amRNSStatement re Offer for Subscription
24th Apr 20142:46 pmRNSOffer for Subscription - Supplementary Prospectus
15th Apr 201410:09 amRNSInterim Management Statement
7th Apr 20144:16 pmRNSOffer for Subscription - Supplementary Prospectus
7th Apr 201411:29 amRNSIssue of Equity
18th Mar 20147:00 amRNSOffer for Subscription - Supplementary Prospectus
4th Mar 20143:56 pmRNSAnnual Financial Report
13th Feb 201410:42 amRNSDirector/PDMR Shareholding
10th Feb 20146:05 pmRNSOffer for Subscription - Supplementary Prospectus
5th Feb 20144:20 pmRNSIssue of Equity
3rd Jan 201411:09 amRNSDirectorate Change
27th Nov 20132:04 pmRNSReplacement Result of General Meeting
27th Nov 20131:33 pmRNSResult of EGM
24th Oct 20136:11 pmRNSOffer for Subscription
17th Oct 20132:39 pmRNSInterim Management Statement
25th Sep 201311:33 amRNSStatement re Proposed Joint Fund Raising
30th Aug 20133:34 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.